SQUAMOUS CELL CARCINOMA OF SKIN

This adverse event was reported 6044 times

These drugs are most commonly taken by patients reporting SQUAMOUS CELL CARCINOMA OF SKIN:

# Drug Count
0 LENALIDOMIDE 766
1 PREDNISONE 641
2 TACROLIMUS 587
3 TACROLIMUS EXTENDED-RELEASE CAPSULES 552
4 TACROLIMUS OINTMENT 0.1% 552
5 ADALIMUMAB 476
6 MYCOPHENOLATE MOFETIL 458
7 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 458
8 DEXAMETHASONE 421
9 DEXAMETHASONE 1.5 MG 421
See all common drugs associated with SQUAMOUS CELL CARCINOMA OF SKIN

SQUAMOUS CELL CARCINOMA OF SKIN is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BREXUCABTAGENE AUTOLEUCEL 75 0.0348
1 ACITRETIN 58 0.0118
2 ERGOCALCIFEROL 345 0.0116
3 VORICONAZOLE 336 0.0109
4 VEMURAFENIB 120 0.0100
5 AXICABTAGENE CILOLEUCEL 99 0.0097
6 SIROLIMUS 120 0.0088
7 VALGANCICLOVIR 100 0.0052
8 EVEROLIMUS TABLETS 87 0.0051
9 TACROLIMUS OINTMENT 0.1% 552 0.0043
See all drugs enriched for association with SQUAMOUS CELL CARCINOMA OF SKIN